Author

L. Massenet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

V. Soumelis· 2 shared A. Moreira· 1 shared A. Schnitzler· 1 shared A. Surun· 1 shared C. Hoffmann· 1 shared C. Le Tourneau· 1 shared C. Lecerf· 1 shared C. Rousseau· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

V. Soumelis

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single cell RNA sequencing of blood antigen-presenting cells in severe Covid-19 reveals multi-process defects in antiviral immunity

M. Saichi, M. Z. Ladjemi, S. Korniotis, C. Rousseau, Z. Ait-Hamou, L. Massenet, E. Amblard, F. Noel, Y. Marie, D. Bouteiller, J. Medvedovic, F. Pene, V. Soumelis

This study uses single-cell RNA sequencing to analyze blood antigen-presenting cells in severe COVID-19 patients, identifying defects in antiviral immunity.

bioRxiv · Jul 20, 2020Immunology

MMP2 As An Independent Prognostic Stratifier In Oral Cavity Cancers

C. Hoffmann, S. Vacher, P. Sirven, C. Lecerf, L. Massenet, A. Moreira, A. Surun, A. Schnitzler, J. Klijanienko, O. Mariani, E. Jeannot, N. Badois, M. Lesnik, O. Choussy, C. Le Tourneau, , V. Soumelis

The paper identifies MMP2 as an independent prognostic biomarker for oral cavity cancers, associated with poor disease-specific survival.

bioRxiv · Aug 2, 2019Cancer Biology